ONI is a pioneer of next generation super-resolution microscopy, making this advanced technology accessible to new generations of researchers. The Nanoimager, the world's first benchtop sized super-resolution microscope, delivers a step change in usability and precision.

The microscope offers easy access to a range of super-resolution techniques including dSTORM and PALM, as well as smFRET, single-particle tracking and confocal.

The company's achievements have been recognised by FastTrack100 who named ONI on their 2018 list of 10 Disruptors to Watch and ONI won Best Business Start-up at the 2018 IOP Awards.

More and more life science researchers and pharma companies are taking an interest in ONI and it now has customers using its products in leading laboratories across the globe, including the Universities of Oxford, Cambridge and Harvard.

ONI has a restless enthusiasm to make the world a better place. Our ambition is to bring super-resolution fluorescence imaging to a new community of researchers and we are removing barriers to make science more effective, accessible and affordable. We have a vision for making high tech science available to anyone, anywhere, from the research bench to your doctor’s office.

Biotechnology

Patrick Finn

Jason Jell

Grace Desantis

Tony Lialin

Renu Menezes

Simon Leathers

Paul Scagnetti

Bo Jing

ONI's Board of Directors includes Patrick Finn.

Board of Directors

CEO and Executive Team

Leadership Team

Board of Directors

About

Team members

Other teams at ONI

CEO and Executive Team

Leadership Team